Tag: AC0676
Accutar Biotechnology Announces First Patient Dosed with AC0676 in Phase 1 Study in Patients with Relapsed/Refractory B-cell Malignancies
Business News
0
0
0
21 Jun, 12:10 PM
Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in B-cell Malignancies
Business News
0
0
0
6 Feb, 10:57 AM
